• The ALL ALS Consortium’s Open Science Initiative

    Bio-IT World | The Access for All in ALS (ALL ALS) Consortium is spearheading an ambitious open science initiative that aims to transform how we understand and treat this devastating neurological disease. Led by Robert Bowser, Ph.D. of the Barrow Neurological Institute and James Berry, M.D. of Massachusetts General Hospital, the consortium is conducting two studies: ASSESS for people living with ALS and healthy controls and PREVENT for those with genetic risk factors but no symptoms.

    May 27, 2025

  • CURATE.AI: How Digital Twins Are Revolutionizing Precision Dosing

    Bio-IT World | Singapore researchers have developed an innovative artificial intelligence platform that creates personalized “digital twins” of patients to optimize drug dosing on an individual basis. The CURATE.AI platform, developed by Dr. Dean Ho and his team at the National University of Singapore's Institute for Digital Medicine (WisDM), represents a significant advancement in precision medicine by dynamically adjusting treatment regimens based on real-time patient responses.

    May 22, 2025

  • Innovative Practices Winner: Chromatography Data Management

    Bio-IT World | Genmab partnered with Genedata to address the challenges of capturing chromatography data. Their effort earned them a 2025 Innovative Practices Awards for their joint development of Chromatics, a new Genedata product developed to meet the needs of chromatography data. In their pursuit of differentiated therapeutic antibodies, Genmab found chromatography data a particularly unwieldy piece of the pipeline.

    May 21, 2025

  • Regeneron Acquires 23andMe for $256 Million

    Bio-IT World | DNA testing company 23andMe was purchased by Regeneron for $256 million. The deal is expected to close on July 1. The deal includes “substantially all assets” of 23and Me, but it will not include Lemonaid Health, a telehealth services provider that 23andMe plans to gradually close.

    May 20, 2025

  • Trends from the Trenches: Data, Discovery, Politics

    Bio-IT World | Ari Berman, CEO of Bio Team, opened the Trends from the Trenches session at the Bio-IT World Conference & Expo by following the data journey from generation to application and outlining the pain points along the way. At the end of his presentation, he got political, challenging the audience to stay engaged in science and the scientific community no matter the political winds.

    May 15, 2025

  • Sweden's PROMISE Initiative: Bridging Research and Healthcare Through Multi-Omics

    Bio-IT World | Sweden is positioning itself at the forefront of precision medicine with an ambitious new initiative that aims to transform how scientific research translates to patient care. The Precision Omics Initiative Sweden (PROMISE), recently outlined in Nature Medicine, seeks to revolutionize healthcare by creating a seamless flow of data between research laboratories and clinical settings.

    May 14, 2025

  • CFDE Unites Data Enthusiasts During Hackathon before Kick-Off of Bio-IT World Conference

    Bio-IT World | Last month, a cohort of 40 participants convened for the Common Fund Data Ecosystem Open Source and FAIR Data Hackathon at the 6th Annual Bio-IT World Hackathon held April 1–2, 2025 in Boston, Mass. Teams tackled a broad range of challenges including linking glycoenzyme expression to disease pathways, enabling cellular-level comparisons using HuBMAP imaging data, and more.

    May 13, 2025